Zobrazeno 1 - 10
of 41
pro vyhledávání: '"Wei, Qi‐Yao"'
Autor:
Tian-Tian Li, Wei-Qi Yao, Hai-Bo Dong, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Lei Shi, Fu-Sheng Wang
Publikováno v:
Stem Cell Research & Therapy, Vol 14, Iss 1, Pp 1-11 (2023)
Abstract Background The objective of this study was to identify potential biomarkers for predicting response to MSC therapy by pre-MSC treatment plasma proteomic profile in severe COVID-19 in order to optimize treatment choice. Methods A total of 58
Externí odkaz:
https://doaj.org/article/a74c9b25ca614aa7b23375336555ea90
Autor:
Tian-Tian Li, Bo Zhang, Hui Fang, Ming Shi, Wei-Qi Yao, Yuanyuan Li, Chao Zhang, Jinwen Song, Lei Huang, Zhe Xu, Xin Yuan, Jun-Liang Fu, Cheng Zhen, Yu Zhang, Ze-Rui Wang, Zi-Ying Zhang, Meng-Qi Yuan, Tengyun Dong, Ruidan Bai, Lulu Zhao, Jianming Cai, Jinghui Dong, Jianzeng Zhang, Wei-Fen Xie, Yonggang Li, Lei Shi, Fu-Sheng Wang
Publikováno v:
EBioMedicine, Vol 92, Iss , Pp 104600- (2023)
Summary: Background: Long-term effects of human mesenchymal stem cell (MSC) treatment on COVID-19 patients have not been fully characterized. The aim of this study was to evaluate the safety and efficacy of a MSC treatment administered to severe COVI
Externí odkaz:
https://doaj.org/article/3b283893b18e47c5a4cb7e255aabc5e4
Autor:
Wu, Dan-Dan, Dai, Li-Juan, Tan, Heng Wee, Zhao, Xiao-Yun, Wei, Qi-Yao, Zhong, Qiu-Hua, Ji, Yan-Chen, Yin, Xiao-Hui, Yu, Fei-Yuan, Jin, Dong-Yan, Li, Sheng-Qing, Lau, Andy T.Y., Xu, Yan-Ming
Publikováno v:
In iScience 22 December 2022 25(12)
Autor:
Lei Shi, Hai Huang, Xuechun Lu, Xiaoyan Yan, Xiaojing Jiang, Ruonan Xu, Siyu Wang, Chao Zhang, Xin Yuan, Zhe Xu, Lei Huang, Jun-Liang Fu, Yuanyuan Li, Yu Zhang, Wei-Qi Yao, Tianyi Liu, Jinwen Song, Liangliang Sun, Fan Yang, Xin Zhang, Bo Zhang, Ming Shi, Fanping Meng, Yanning Song, Yongpei Yu, Jiqiu Wen, Qi Li, Qing Mao, Markus Maeurer, Alimuddin Zumla, Chen Yao, Wei-Fen Xie, Fu-Sheng Wang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-9 (2021)
Abstract Treatment of severe Coronavirus Disease 2019 (COVID-19) is challenging. We performed a phase 2 trial to assess the efficacy and safety of human umbilical cord-mesenchymal stem cells (UC-MSCs) to treat severe COVID-19 patients with lung damag
Externí odkaz:
https://doaj.org/article/9be719bb4ddd4d37b35173df4303eea1
Autor:
Wei, Qi-Yao1 (AUTHOR), Lau, Andy T. Y.1 (AUTHOR), Mo, Hai-Ying1,2 (AUTHOR), Zhong, Qiu-Hua1 (AUTHOR), Zhao, Xiao-Yun1 (AUTHOR), Yu, Fei-Yuan1 (AUTHOR), Han, Jin1 (AUTHOR), Wu, Yu-Yao1 (AUTHOR), Xu, Yan-Ming1 (AUTHOR) amyymxu@stu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Jan2023, Vol. 24 Issue 1, p113. 17p.
Autor:
Zhang, Yu‐Xin1,2 (AUTHOR), Wei, Qi‐Yao1 (AUTHOR), Wang, Ya‐Tao3 (AUTHOR), Zeng, Li‐Ping3 (AUTHOR), Sun, Shi‐Yu4 (AUTHOR), Wu, Yong‐Fang3 (AUTHOR), Ren, Chong‐Yang3 (AUTHOR), Wang, Fang5 (AUTHOR), Chen, Gui‐Hai3 (AUTHOR) y1520989@163.com, Cao, Lei1 (AUTHOR) caolei0531@163.com
Publikováno v:
Brain & Behavior. Dec2022, Vol. 12 Issue 12, p1-12. 12p.
Autor:
Mo, Hai-Ying1,2 (AUTHOR) 16hymo@alumni.stu.edu.cn, Wei, Qi-Yao1 (AUTHOR) 19qywei@stu.edu.cn, Zhong, Qiu-Hua1 (AUTHOR) 17qhzhong@stu.edu.cn, Zhao, Xiao-Yun1 (AUTHOR) 18xyzhao@stu.edu.cn, Guo, Dan3 (AUTHOR) dguo@stu.edu.cn, Han, Jin1 (AUTHOR) 16jhan1@alumni.stu.edu.cn, Noracharttiyapot, Wachiraporn1 (AUTHOR) nora@stu.edu.cn, Visser, Lydia2 (AUTHOR) a.van.den.berg01@umcg.nl, van den Berg, Anke2 (AUTHOR), Xu, Yan-Ming1 (AUTHOR) amyymxu@stu.edu.cn, Lau, Andy T. Y.1 (AUTHOR) amyymxu@stu.edu.cn
Publikováno v:
International Journal of Molecular Sciences. Jul2022, Vol. 23 Issue 14, p7853-7853. 22p.
Publikováno v:
Brain Research Bulletin. 177:92-102
Background Mesenchymal stem cells (MSCs) therapy has great potential for Alzheimer’s disease (AD) treatment. Here, we investigated the roles of BMSCs-exosomes containing growth differentiation factor-15 (GDF-15) in regulating SH-SY5Y cell injury in
Publikováno v:
Stem cells translational medicine. 11(9)
Chronic liver diseases have become a significant health issue worldwide and urgently require the development of novel therapeutic approaches, in addition to liver transplantation. Recent clinical and preclinical studies have shown that cell-based the
Publikováno v:
SSRN Electronic Journal.